Patents Assigned to Ipca Laboratories
  • Anti-thrombotic compounds
    Patent number: 10105353
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Grant
    Filed: October 3, 2013
    Date of Patent: October 23, 2018
    Assignee: IPCA LABORATORIES LIMITED
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki Moje
  • Pharmaceutical composition
    Patent number: 9492406
    Abstract: The present invention relates to a novel pharmaceutical composition having enhanced bioavailability through improved aqueous dissolution of poorly water soluble drugs, and to a method for preparing it. The invention more particularly relates to an oral pharmaceutical composition containing active ingredients of poor aqueous solubility, more specifically, antiparasitic and antipneumocystic drug Atovaquone alone or in combination with Proguanil.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: November 15, 2016
    Assignee: Ipca Laboratories Ltd.
    Inventors: Ashok Kumar, Dharmendra Singh, Pramilkumar Mathur, Thankachen Byju Nellithanath, Gaurav Sahal, Rakesh Kumar Bhasin, Durga Prasad Samantaray
  • Methods for the treatment or prophylaxis of thrombosis or embolism
    Patent number: 9321785
    Abstract: The present invention relates to a method of ameliorating the drawbacks of anti-platelet drug named clopidogrel. The method of the present invention comprises administration of an (S)oxo-clopidogrel or its derivative of the Formula IIA in its free or pharmaceutically acceptable salt form for alleviating the symptoms of thrombosis or embolism by inhibiting blood platelet aggregation. Compositions for use in such methods are also provided.
    Type: Grant
    Filed: August 7, 2013
    Date of Patent: April 26, 2016
    Assignee: IPCA Laboratories Limited
    Inventors: Ashok Kumar, Nellithanath Thankachen Byju
  • Complex for treatment and/or prophylaxis of parasitic infections
    Patent number: 8987234
    Abstract: Disclosed are complexes of an antipneumocystic compound and an antimalarial compound, processes for their preparation, pharmaceutical compositions and methods of using said complexes or compositions for the treatment and/or prophylaxis of parasitic infections.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: March 24, 2015
    Assignee: IPCA Laboratories Ltd.
    Inventors: Ashok Kumar, Dharmendra Singh, Pramilkumar Mathur, Vitthal Syryabhan Buchude
  • PHARMACEUTICAL COMBINATION
    Publication number: 20140128402
    Abstract: The present invention discloses a pharmaceutical combination comprising Hydroxychloroquine and a DPP-IV inhibitor or their pharmaceutically acceptable salts, solvates or prodrugs thereof, for preventing, slowing the progression of, delaying, improving, restoring, or treating a condition or a disease resulting from metabolic disorders.
    Type: Application
    Filed: January 10, 2014
    Publication date: May 8, 2014
    Applicant: IPCA Laboratories Limited
    Inventors: Anil PAREEK, Gopakumar G. NAIR
  • Anti-Thrombotic Compounds
    Publication number: 20140038924
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Application
    Filed: October 3, 2013
    Publication date: February 6, 2014
    Applicant: IPCA LABORATORIES LIMITED
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki MOJE
  • Anti-Thrombotic Compounds
    Publication number: 20140031320
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Application
    Filed: October 3, 2013
    Publication date: January 30, 2014
    Applicant: IPCA LABORATORIES LIMITED
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki MOJE
  • METHODS FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM
    Publication number: 20140018331
    Abstract: The present invention relates to a method of ameliorating the drawbacks of anti-platelet drug named clopidogrel. The method of the present invention comprises administration of an (S)oxo-clopidogrel or its derivative of the Formula IIA in its free or pharmaceutically acceptable salt form for alleviating the symptoms of thrombosis or embolism by inhibiting blood platelet aggregation. Compositions for use in such methods are also provided.
    Type: Application
    Filed: August 7, 2013
    Publication date: January 16, 2014
    Applicant: IPCA Laboratories Limited
    Inventors: Ashok KUMAR, Nellithanath Thankachen Byju
  • Anti-Thrombotic Compounds
    Publication number: 20130316987
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Application
    Filed: August 1, 2013
    Publication date: November 28, 2013
    Applicant: IPCA LABORATORIES LIMITED
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki MOJE
  • Anti-Thrombotic Compounds
    Publication number: 20130316986
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Application
    Filed: August 1, 2013
    Publication date: November 28, 2013
    Applicant: IPCA LABORATORIES LIMITED
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki MOJE
  • Methods for the treatment or prophylaxis of thrombosis or embolism
    Patent number: 8541422
    Abstract: The present invention relates to a method of ameliorating the drawbacks of anti-platelet drug named clopidogrel. The method of the present invention comprises administration of an (S)oxo-clopidogrel or its derivative of the Formula IIA in its free or pharmaceutically acceptable salt form for alleviating the symptoms of thrombosis or embolism by inhibiting blood platelet aggregation. Compositions for use in such methods are also provided.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: September 24, 2013
    Assignee: IPCA Laboratories Limited
    Inventors: Ashok Kumar, Nellithanath Thankachen Byju
  • Solid forms of methyl (7aS,2?S)-2-(2-chlorophenyl)-2-(2,4,5,6,7,7a-hexahydrothieno[3,2-c]-5-pyridin-2-one)acetate
    Patent number: 8536337
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: September 17, 2013
    Assignee: IPCA Laboratories Limited
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki Moje
  • Pharmaceutical compositions for the treatment of diabetes mellitus
    Patent number: 8415360
    Abstract: Disclosed herein is a pharmaceutical composition comprising Hydroxychloroquine or its pharmaceutically acceptable salt and at least one antidiabetic compound, useful in the treatment of diabetes mellitus.
    Type: Grant
    Filed: September 23, 2009
    Date of Patent: April 9, 2013
    Assignee: IPCA Laboratories Limited
    Inventor: Anil Pareek
  • NOVEL COMPLEX FOR TREATMENT AND/OR PROPHYLAXIS OF PARASITIC INFECTIONS
    Publication number: 20120136062
    Abstract: Disclosed are complexes of an antipneumocystic compound and an antimalarial compound, processes for their preparation, pharmaceutical compositions and methods of using said complexes or compositions for the treatment and/or prophylaxis of parasitic infections.
    Type: Application
    Filed: August 20, 2010
    Publication date: May 31, 2012
    Applicant: IPCA Laboratories Ltd.
    Inventors: Ashok Kumar, Dharmendra Singh, Pramilkumar Mathur, Vitthal Syryabhan Buchude
  • METHODS FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM
    Publication number: 20120053157
    Abstract: The present invention relates to a method of ameliorating the drawbacks of anti-platelet drug named clopidogrel. The method of the present invention comprises administration of an (S)oxo-clopidogrel or its derivative of the Formula IIA in its free or pharmaceutically acceptable salt form for alleviating the symptoms of thrombosis or embolism by inhibiting blood platelet aggregation. Compositions for use in such methods are also provided.
    Type: Application
    Filed: August 26, 2011
    Publication date: March 1, 2012
    Applicant: IPCA LABORATORIES LIMITED
    Inventors: Ashok Kumar, Nellithanath Thankachen Byju
  • PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETES MELLITUS
    Publication number: 20110230501
    Abstract: Disclosed herein is a pharmaceutical composition comprising Hydroxychloroquine or its pharmaceutically acceptable salt and at least one antidiabetic compound, useful in the treatment of diabetes mellitus.
    Type: Application
    Filed: September 23, 2009
    Publication date: September 22, 2011
    Applicant: IPCA Laboratories Ltd.
    Inventor: Anil Pareek
  • PROCESS FOR PREPARATION OF MYCOPHENOLIC ACID, ITS SALT AND ESTER DERIVATIVES
    Publication number: 20110166347
    Abstract: The present invention discloses an isolation and purification process for mycophenolic acid obtained from the fermentation process. Invention further discloses preparation of sodium salt of mycophenolic acid and mycophenolate mofetil from mycophenolic acid.
    Type: Application
    Filed: September 9, 2009
    Publication date: July 7, 2011
    Applicant: IPCA Laboratories Ltd.
    Inventors: Ashok Kumar, Dharmendra Singh, Umesh Luthara, Yogesh Mohandhai Patel
  • Industrial preparation of 11-[4-{2-(2-hydroxyethoxy) ethyl}-1-piperazinyl] dibenzo [b,f]-[1,4]thiazepine
    Patent number: 7847094
    Abstract: Disclosed herein is an industrial preparation of Quetiapine by the reaction of 11-piperazinyldibenzo[b,f][1,4]-thiazepine or its salt with 2-(2-chloroethoxy)ethanol in presence of an organic or inorganic base under neat or aqueous condition to form 11-[4-{2-(2-hydroxyethoxy)ethyl}-1-piperazinyl]dibenzo[b,f]-[1,4]thiazepine. The quetiapine free base obtained is further converted to its hemi-fumarate salt.
    Type: Grant
    Filed: June 8, 2007
    Date of Patent: December 7, 2010
    Assignee: IPCA Laboratories Limited
    Inventors: Ashok Kumar, Dharmendra Singh, Swapnali Hemant Patil, Ganesh Devidas Mahale, Uttamrao Arjunrao Sawant, Balasaheb Ganpat Jadhav, Ragneshkumar Rana
  • Process for preparation of atovaquone and novel intermediates thereof
    Patent number: 7847127
    Abstract: Disclosed herein is a novel process for preparation of atovaquone. The process includes reacting 1,4-naphthoquinone with trans-4-(4-chlorophenyl) cyclohexane carboxylic acid followed by halogenation to obtain a dihalo-compound. Further, dehydrohalogenation of the dihalo-compound produces a monohalogeno-compound which under goes hydrolysis to produce atovaquone. The invention also discloses atovaquone in a substantially pure and well defined polymorphic form designated as “Form IPCA-ATO,” and the preparation thereof.
    Type: Grant
    Filed: October 21, 2009
    Date of Patent: December 7, 2010
    Assignee: IPCA Laboratories Limited
    Inventors: Ashok Kumar, Suneel Yeshwant Dike, Pramil Kumar Mathur, Nellithanath Thankachen Byju, Brajesh Sharma, Swapnil Shreekant Kore, Vitthal Suryabhan Buchude, Dharmendra Singh
  • PROCESS FOR OPTICALLY ACTIVE SULFOXIDE COMPOUNDS
    Publication number: 20100210848
    Abstract: The present invention discloses novel processes for preparing optically active sulphoxide compounds of formula I by asymmetric oxidation of prochiral sulphide compounds of Formula II. More particularly, the invention discloses processes for preparation of optically active proton pump Inhibitors (PPIs) or their optically active precursor (=intermediate) compounds (Formula I) that can be converted into pharmaceutically useful PPIs.
    Type: Application
    Filed: October 3, 2008
    Publication date: August 19, 2010
    Applicant: IPCA Laboratories Ltd.
    Inventors: Ashok Kumar, Dharmendra Singh, Nellithanath Thankachen Byju, Prasad Shankar Kadam, Harishankar Prahladkumar Vishwakarma, Vijay Ojha, Umeshkumar Suresh Ninawe